The Safety and Efficacy of Transcatheter Edge-to-Edge Mitral Valve Repair for Central versus Non-central Primary Mitral Regurgitation: A Single-center Cohort Study
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
It remains unclear whether transcatheter edge-to-edge mitral valve repair (M-TEER) ensures procedural safety and 30-day and one-year efficacy in non-central primary mitral regurgitation (pMR) compared to central pMR.
Objectives
This study assessed clinical and echocardiographic outcomes of M-TEER in non-central pMR compared with central pMR.
Methods
This study included consecutive patients with pMR who underwent M-TEER at a single center between April 2018 and December 2022. Data were prospectively collected and analyzed retrospectively. Baseline clinical and echocardiographic characteristics, as well as procedural and clinical outcomes up to 1-year post procedure, were compared between patients with non-central pMR group (NCpMR) and those with central pMR group (CpMR).
Results
Among 129 patients with pMR who underwent M-TEER, 50 had NCpMR and 79 had CpMR. Neither group had 30-day mortality. Although residual MR grade 3+/4+ was more frequent in NCpMR than CpMR (10.0% vs. 0.8%, p = 0.01), MR worsening was lower in NCpMR at 6 months (5.0% vs. 10.5%, p = 0.18) and 12 months (7.5% vs. 27.7%, p = 0.03). A 30-day landmark analysis showed a trend towards a lower prevalence of residual MR grade 3+/4+ at 1 year in NCpMR (p = 0.051).
Conclusions
No significant differences in 30-day mortality and emergent intervention for complications were noted among two groups. Although MR grade at discharge was better in CpMR, NCpMR showed lower MR worsening and sustained MR reduction at 1-year. M-TEER can be an option for non-central pMR in high-risk surgical patients.
